









Markets
/
Stocks
/
nasdaq-rdnt
/

RadNet Inc

RDNT

69.240USD

+4.720+7.32%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

5.33BMarket Cap

LossP/E TTM



RadNet Inc

69.240

+4.720+7.32%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of RadNet Inc

Currency: USD Updated: 2026-02-06

Key Insights

RadNet Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 53 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 91.75.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

RadNet Inc's Score

Industry at a Glance

Industry Ranking

53 / 75

Overall Ranking

239 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

RadNet Inc Highlights

StrengthsRisks

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.94% year-on-year.

Undervalued

The company’s latest PE is -411.43, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 74.61M shares, decreasing 2.07% quarter-over-quarter.

Held by Ron Baron

Star Investor Ron Baron holds 810.07K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.56.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

91.750

Target Price

+42.20%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of RadNet Inc is 4.97, ranking 72 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 522.87M, representing a year-over-year increase of 13.39%, while its net profit experienced a year-over-year increase of 68.81%.

Score

Industry at a Glance

Previous score

4.97

Change



Financials

8.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.44

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.12

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

5.00

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

RadNet Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of RadNet Inc is 7.45, ranking 30 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -411.43, which is -562.40% below the recent high of 1902.46 and -217.00% above the recent low of -1304.24.

Score

Industry at a Glance

Previous score

7.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 53/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of RadNet Inc is 8.75, ranking 3 out of 75 in the Healthcare Providers & Services industry. The average price target is 91.00, with a high of 98.00 and a low of 86.00.

Score

Industry at a Glance

Previous score

8.75

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

91.750

Target Price

+42.20%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

RadNet Inc

RDNT

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of RadNet Inc is 7.09, ranking 33 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 78.97 and the support level at 61.75, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.52

Change

0.57

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.899

Sell

RSI(14)

43.639

Neutral

STOCH(KDJ)(9,3,3)

29.593

Buy

ATR(14)

2.989

High Vlolatility

CCI(14)

-133.597

Sell

Williams %R

52.359

Neutral

TRIX(12,20)

-0.310

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

68.484

Buy

MA10

70.148

Sell

MA20

71.782

Sell

MA50

74.288

Sell

MA100

75.881

Sell

MA200

67.776

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of RadNet Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 96.40%, representing a quarter-over-quarter increase of 0.04%. The largest institutional shareholder is The Vanguard, holding a total of 7.45M shares, representing 9.62% of shares outstanding, with 0.90% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

8.63M

+1.44%

The Vanguard Group, Inc.

Star Investors

7.47M

+1.27%

Kaminsky (Sandy Nyholm)

4.55M

-15.34%

Beck, Mack & Oliver LLC

3.28M

+0.42%

RTW Investments L.P.

2.82M

+4.65%

State Street Investment Management (US)

2.54M

+2.23%

Stolper (Mark D)

2.36M

+1.54%

T. Rowe Price Associates, Inc.

Star Investors

2.01M

+2051.66%

Geode Capital Management, L.L.C.

1.66M

+1.51%

JB Capital Partners, L.P.

1.42M

-3.39%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for RadNet Inc. The Healthcare Providers & Services industry's average is 5.62. The company's beta value is 1.50. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.